Summary
Updated Aug 30, 2026
Radhika Tripuraneni is Chief Medical Officer of Viridian Therapeutics, Inc.\DE (VRDN). 4 SEC Form 4 filings on record, most recently on 18 August 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Radhika Tripuraneni has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Radhika Tripuraneni files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $30.00M of VRDN open-market activity in the last 12 months
- Jennifer Tousignant - $419K of VRDN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Radhika Tripuraneni?
Radhika Tripuraneni is a corporate insider, tracked as Chief Medical Officer of Viridian Therapeutics, Inc.\DE (VRDN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Radhika Tripuraneni submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Radhika Tripuraneni's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Radhika Tripuraneni and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
